EMA begins rolling review of Pfizer-BioNTech’s Covid-19 vaccine
Pfizer and BioNTech also intend to commence the submission of data supporting a potential variant-adapted vaccine to the FDA.
Covid-19
Latest in
Covid-19
Sheffield and Stanford university teams discovers genes linked to Covid-19
The researchers found that severe Covid-19 is mostly linked to a weakened response from two immune cells.
Australia grants provisional registration for Novavax’s Covid-19 booster
The latest provisional registration is based on findings from two Phase II trials and the COV-BOOST trial of the vaccine.
EMA’s PRAC finds no link between mRNA Covid-19 vaccines and menstruation
The existing data do not support a causal link and a product information update for either of the vaccines, PRAC…
FDA committee recommends EUA for Novavax’s Covid-19 vaccine
In the Phase III PREVENT-19 trial, the vaccine offered an efficacy of 90.4% with a reassuring safety profile.
Catalent, MigVax enter deal to develop tablet vaccine for Covid-19
Zydis technology produces a freeze-dried tablet that dissolves quickly in the mouth without needing water.
Veru seeks FDA EUA for oral antiviral drug to treat Covid-19
The EUA is based on the positive data from a Phase III trial of sabizabulin in nearly 204 hospitalised Covid-19…
Emergent sends notice to Janssen over Covid-19 vaccine contract
The notice says that Janssen intends to not purchase the minimum quantity of product mentioned in the initial agreement.